Patents by Inventor Wei-Guo Su

Wei-Guo Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTRACTS OF ANDROGRAPHIS PANICULATA, METHODS FOR PREPARATION AND USE THEREOF
    Publication number: 20190240275
    Abstract: Disclosed herein are extracts of Andrographis paniculata having highly concentrated active ingredients, preparation methods and medical use for treating autoimmunity and inflammatory disease.
    Type: Application
    Filed: November 1, 2017
    Publication date: August 8, 2019
    Inventors: Wei-Guo Su, Xiong Li, Weihan Zhang, Bo Liu, Huaqing Cai, Zhilong Weng, Hongqiang Wang, Zhiyong Yu, Lei Jiang
  • Pyrrolopyrimidine compounds and uses thereof
    Patent number: 10369153
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: August 6, 2019
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jinshui Li, Jianguo Ji
  • NOVEL IMIDAZOPYRIDAZINE COMPOUNDS AND THEIR USE
    Publication number: 20190127391
    Abstract: This disclosure provides novel imidazopyridazine compounds of formula (I) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting PI3K and potential use in treating a disease responsive to inhibition of PI3K, for example, an inflammatory disease, autoimmune disease or cancer.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 2, 2019
    Inventors: Wei-Guo Su, Guangxiu Dai, Weihan Zhang, Wei Deng
  • PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20190060319
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical comp6sitions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Inventors: Wei-Guo SU, Wei DENG, Jinshui LI, Jianguo JI
  • Imidazopyridazine compounds and their use
    Patent number: 10208066
    Abstract: This disclosure provides novel imidazopyridazine compounds of formula (I) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting PI3K and potential use in treating a disease responsive to inhibition of PI3K, for example, an inflammatory disease, autoimmune disease or cancer.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: February 19, 2019
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Guangxiu Dai, Welhan Zhang, Wei Deng
  • Pyrrolopyrimidine compounds and uses thereof
    Patent number: 10111875
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: October 30, 2018
    Assignee: HUTCHINSON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jinshui Li, Jianguo Ji
  • CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
    Publication number: 20180263977
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: April 4, 2018
    Publication date: September 20, 2018
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
    Patent number: 10052330
    Abstract: Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: August 21, 2018
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jianguo Ji
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 9956218
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: May 1, 2018
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • NOVEL IMIDAZOPYRIDAZINE COMPOUNDS AND THEIR USE
    Publication number: 20170253618
    Abstract: This disclosure provides novel imidazopyridazine compounds of formula (I) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting PI3K and potential use in treating a disease responsive to inhibition of PI3K, for example, an inflammatory disease, autoimmune disease or cancer.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 7, 2017
    Inventors: Wei-Guo Su, Guangxiu Dai, Welhan Zhang, Wei Deng
  • Pyrimidine and pyridine compounds and their usage
    Patent number: 9701680
    Abstract: The present invention relates to novel pyrimidine and pyridine compounds of formula (I) or a pharmaceutical acceptable salt thereof, wherein R1, R2, R3, R4, R5, X, Y and G are as defined in the description, to pharmaceutical compositions containing them, a process for preparing them, and their use in therapy of a disease responsive to inhibition of FGFR, for example, cancer.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 11, 2017
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Weihan Zhang, Jinshui Li
  • Substituted Pyridopyrazines as Syk Inhibitors
    Publication number: 20170152258
    Abstract: The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, L, m, p and W are as defined in the specification.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 1, 2017
    Inventors: Wei-Guo SU, Wei DENG
  • CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
    Publication number: 20170027934
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: October 14, 2016
    Publication date: February 2, 2017
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
    Publication number: 20160324864
    Abstract: Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
    Type: Application
    Filed: July 15, 2016
    Publication date: November 10, 2016
    Inventors: Wei-Guo SU, Wei DENG, Jianguo JI
  • Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
    Patent number: 9434726
    Abstract: Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: September 6, 2016
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jianguo Ji
  • PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20160228443
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Inventors: Wei-Guo SU, Wei DENG, Jinshui LI, Jianguo JI
  • Pyrrolopyrimidine compounds and uses thereof
    Patent number: 9346810
    Abstract: The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
    Type: Grant
    Filed: August 18, 2011
    Date of Patent: May 24, 2016
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Wei Deng, Jinshui Li, Jianguo Ji
  • NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF
    Publication number: 20160052926
    Abstract: The present invention relates to novel pyrimidine and pyridine compounds of formula (I) or a pharmaceutical acceptable salt thereof, wherein R1, R2, R3, R4, R5, X, Y and G are as defined in the description, to pharmaceutical compositions containing them, a process for preparing them, and their use in therapy of a disease responsive to inhibition of FGFR, for example, cancer.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 25, 2016
    Inventors: Wei-Guo SU, Weihan ZHANG, Jinshui LI
  • NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR USAGE
    Publication number: 20160024021
    Abstract: The present invention relates to novel pyrimidine and pyridine compounds of formula (I) or a pharmaceutical acceptable salt thereof, wherein R1, R2, R3, R4, R5, X, Y and G are as defined in the description, to pharmaceutical compositions containing them, a process for preparing them, and their use in therapy of a disease responsive to inhibition of FGFR, for example, cancer.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Wei-Guo SU, Weihan ZHANG, Jinshui LI
  • Substituted Pyridopyrazines as Syk Inhibitors
    Publication number: 20160002221
    Abstract: The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, L, m, p and W are as defined in the specification.
    Type: Application
    Filed: December 6, 2013
    Publication date: January 7, 2016
    Inventors: Wei-Guo SU, Wei DENG